Bezlotoxumab Not Yet Recruiting Phase 4 Trials for Clostridium Difficile Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03937999Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.